Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

completed133%
unknown133%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnphase_4

Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)

NCT04374474
completed

Immunity and Nasal Fungal Colonization

NCT05231499
unknownnot_applicable

Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection

NCT03933241

Clinical Trials (3)

Showing 3 of 3 trials
NCT04374474Phase 4

Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)

Withdrawn
NCT05231499

Immunity and Nasal Fungal Colonization

Completed
NCT03933241Not Applicable

Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection

Unknown

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3